Human gene
OCA2 oculocutaneous albinism II
1 disease group in OMIA reaches this gene, through the animal gene that Ensembl gives as its ortholog. The page shows the chain. It does not say whether an animal is a model of a human disease.
Animal diseases
By each group's best natural-model score, highest first. How the score works.
| OMIA group | Name | Species | Animal gene | Ortholog | The chain reached | Best score |
|---|---|---|---|---|---|---|
| 2130 | Oculocutaneous albinism, OCA2-related | dog | OCA2 | one to one | Target evidence |
69.9
|
| 2130 | Oculocutaneous albinism, OCA2-related | Japanese medaka | oca2 | one to one | Target evidence |
69.9
|
| 2130 | Oculocutaneous albinism, OCA2-related | Rhesus monkey | OCA2 | one to one | Target evidence |
69.9
|
Target evidence
Each Open Targets association between this gene and a human disease that a disease group reached.
| Human disease | Mondo | Score | Evidence |
|---|---|---|---|
| oculocutaneous albinism type 2 | MONDO:0008746 | 0.85 | 503 |
Drugs
Each ChEMBL drug that acts on this gene.
No ChEMBL drug acts on this gene, among the genes with target evidence.